Clinical Trials Directory

Trials / Completed

CompletedNCT00499915

NICU Asthma Education and Secondhand Smoke Reduction Study

Preventing Respiratory Illness Among Premature Infants: An Asthma Education and Secondhand Smoke Reduction Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
165 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Premature infants have a significantly increased risk for developing respiratory illnesses and asthma. Secondhand smoke (SHS) also is clearly associated with increased breathing problems in children, thus exposure to smoke makes it substantially more likely for a premature infant to develop wheezing. The overall goal of this study is to test whether comprehensive asthma education combined with a home-based secondhand smoke reduction program can reduce exposure to smoke and prevent respiratory illness among premature infants. Our hypotheses are: * More premature infants whose families receive asthma education combined with a SHS reduction intervention will live in smoke-free environments compared to infants receiving only asthma education (control group). * Caregivers receiving the SHS reduction program will have higher rates of quit attempts and less relapse into smoking compared to caregivers in the control group. * Infants whose families receive the combined intervention will experience less respiratory illness compared to infants in the control group.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSecondhand Smoke Reduction and Smoking Cessation CounselingA secondhand smoke reduction program, including smoking cessation counseling (if appropriate), and feedback about the children's cotinine levels will be implemented using principles of Motivational Interviewing.
BEHAVIORALAsthma EducationAsthma education will be provided at NICU discharge.

Timeline

Start date
2007-02-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2007-07-12
Last updated
2015-11-23
Results posted
2015-11-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00499915. Inclusion in this directory is not an endorsement.